SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-025148
Filing Date
2024-10-15
Accepted
2024-10-15 18:05:05
Documents
1
Period of Report
2024-10-12

Document Format Files

Seq Description Document Type Size
1 form4-10152024_061001.html 4  
1 form4-10152024_061001.xml 4 5555
  Complete submission text file 0001415889-24-025148.txt   7025
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DBV TECHNOLOGIES S.A. 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address
Ndu Adora (Reporting) CIK: 0001865210 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 241372936